The Use of Technetium-99m for Intravital Tracing of Transplanted Multipotent Stromal Cells


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We studied the possibility of in vivo tracing of multipotent mesenchymal stromal cells labeled with a radiophermaceutic preparation based on metastable isotope Technetium-99m and injected to rats with modeled traumatic brain injury. Accumulation of labeled cells occurred primarily in the liver and lungs. The cells distribution in internal organs greatly varied depending on the administration route. Cell injection into the carotid artery led to their significant accumulation in the damaged brain hemisphere, while intravenous injection was followed by diffuse cell distribution in all brain structures. Scintigraphy data were confirmed by magnetic resonance imaging and histological staining of cells. Visualization of stem cells labeled with Technetium-99m-based preparation by scintigraphy is an objective and highly informative method allowing real-time in vivo cell tracing in the body.

About the authors

D. N. Silachev

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation; A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Russian Federation, Moscow; Moscow

A. K. Kondakov

N. I. Pirogov National Russian Research Medical University, Ministry of Health of the Russian Federation; Hospital for Incurable Patients — Research Medical Rehabilitation Center

Email: zorov@genebee.msu.ru
Russian Federation, Moscow; Moscow

I. A. Znamenskii

N. I. Pirogov National Russian Research Medical University, Ministry of Health of the Russian Federation; Hospital for Incurable Patients — Research Medical Rehabilitation Center

Email: zorov@genebee.msu.ru
Russian Federation, Moscow; Moscow

Yu. B. Kurashvili

National Research Nuclear University MEPhI; P. A. Hertsen Moscow Oncology Research Institute

Email: zorov@genebee.msu.ru
Russian Federation, Moscow; Moscow

A. V. Abolenskaya

P. A. Hertsen Moscow Oncology Research Institute

Email: zorov@genebee.msu.ru
Russian Federation, Moscow

N. R. Antipkin

P. A. Hertsen Moscow Oncology Research Institute

Email: zorov@genebee.msu.ru
Russian Federation, Moscow

T. I. Danilina

A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Russian Federation, Moscow

V. N. Manskikh

A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Russian Federation, Moscow

M. V. Gulyaev

Laboratory of Magnetic Tomography and Spectroscopy, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Russian Federation, Moscow

Yu. A. Pirogov

Laboratory of Magnetic Tomography and Spectroscopy, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Russian Federation, Moscow

E. Yu. Plotnikov

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation; A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Russian Federation, Moscow; Moscow

D. B. Zorov

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation; A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Author for correspondence.
Email: zorov@genebee.msu.ru
Russian Federation, Moscow; Moscow

G. T. Sukhikh

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation

Email: zorov@genebee.msu.ru
Russian Federation, Moscow


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies